| abstract |
The present invention uses the N-substituted indole-3-glyoxylamide of Formula 1 as an antitumor agent and contains at least one compound of Formula 1, possibly in the form of a physiologically acceptable salt or N-oxide thereof. It relates to a pharmaceutical composition having an anti-tumor activity characterized in that. In addition, the present invention provides one or more N-substituted indole-3-glyoxylamides as active ingredients and their physiologically acceptable acid addition salts and possible N-oxides as well as physiologically acceptable carriers and / or diluents or additives. It relates to an anti-tumor agent in the form of tablets, coated tablets, capsules, infusion solutions, ampoules, suppositories, patches, inhalable powders, suspensions, creams and ointments. |